Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colitis, Ulcerative | 159 | 2024 | 1919 | 28.280 |
Why?
|
Inflammatory Bowel Diseases | 155 | 2024 | 2420 | 23.660 |
Why?
|
Crohn Disease | 142 | 2024 | 2275 | 21.240 |
Why?
|
Gastrointestinal Agents | 27 | 2022 | 508 | 6.050 |
Why?
|
Biological Therapy | 10 | 2022 | 139 | 5.110 |
Why?
|
Tumor Necrosis Factor-alpha | 30 | 2023 | 4342 | 3.950 |
Why?
|
Clostridium Infections | 16 | 2020 | 557 | 3.400 |
Why?
|
Hospitalization | 47 | 2024 | 10652 | 3.200 |
Why?
|
Colectomy | 15 | 2022 | 692 | 2.800 |
Why?
|
Immunologic Factors | 18 | 2023 | 1585 | 2.570 |
Why?
|
Immunosuppressive Agents | 17 | 2023 | 4158 | 2.110 |
Why?
|
Feces | 21 | 2024 | 1456 | 2.080 |
Why?
|
Biological Products | 8 | 2022 | 906 | 2.040 |
Why?
|
Colonoscopy | 15 | 2023 | 1388 | 1.940 |
Why?
|
Enterocolitis, Pseudomembranous | 7 | 2017 | 264 | 1.790 |
Why?
|
Vitamin D | 13 | 2016 | 3283 | 1.780 |
Why?
|
Gastroenterology | 9 | 2020 | 571 | 1.750 |
Why?
|
Vitamin D Deficiency | 12 | 2018 | 1377 | 1.750 |
Why?
|
Humans | 387 | 2024 | 758406 | 1.730 |
Why?
|
Environment | 5 | 2018 | 1118 | 1.730 |
Why?
|
Leukocyte L1 Antigen Complex | 7 | 2023 | 93 | 1.620 |
Why?
|
Adult | 188 | 2024 | 219935 | 1.540 |
Why?
|
Remission Induction | 19 | 2023 | 2388 | 1.530 |
Why?
|
Severity of Illness Index | 32 | 2024 | 15785 | 1.510 |
Why?
|
Colorectal Neoplasms | 16 | 2021 | 6852 | 1.440 |
Why?
|
Risk Factors | 104 | 2024 | 73809 | 1.430 |
Why?
|
Fatigue | 4 | 2021 | 1542 | 1.380 |
Why?
|
Anti-Inflammatory Agents | 12 | 2021 | 1793 | 1.350 |
Why?
|
Female | 213 | 2024 | 390323 | 1.310 |
Why?
|
Colitis, Microscopic | 5 | 2022 | 72 | 1.280 |
Why?
|
Middle Aged | 149 | 2024 | 219568 | 1.260 |
Why?
|
Multivariate Analysis | 31 | 2021 | 12096 | 1.240 |
Why?
|
Male | 181 | 2024 | 358747 | 1.220 |
Why?
|
Proctocolectomy, Restorative | 4 | 2024 | 190 | 1.180 |
Why?
|
Gastrointestinal Hemorrhage | 8 | 2020 | 1110 | 1.150 |
Why?
|
Immunoglobulin Fab Fragments | 4 | 2015 | 444 | 1.130 |
Why?
|
Prospective Studies | 64 | 2024 | 54137 | 1.110 |
Why?
|
Smoking | 17 | 2024 | 9051 | 1.100 |
Why?
|
Young Adult | 71 | 2024 | 58808 | 1.080 |
Why?
|
Phenotype | 26 | 2024 | 16534 | 1.080 |
Why?
|
Constipation | 5 | 2018 | 561 | 1.070 |
Why?
|
Incidence | 40 | 2024 | 21272 | 1.070 |
Why?
|
Cholangitis, Sclerosing | 4 | 2024 | 177 | 1.060 |
Why?
|
Retrospective Studies | 76 | 2024 | 80168 | 1.040 |
Why?
|
Pouchitis | 2 | 2024 | 64 | 1.020 |
Why?
|
Electronic Health Records | 18 | 2020 | 4761 | 1.010 |
Why?
|
Environmental Exposure | 6 | 2024 | 4412 | 0.980 |
Why?
|
Anus Diseases | 2 | 2014 | 55 | 0.950 |
Why?
|
Antirheumatic Agents | 3 | 2022 | 1368 | 0.950 |
Why?
|
Aged | 99 | 2024 | 168218 | 0.920 |
Why?
|
Cohort Studies | 44 | 2024 | 41256 | 0.910 |
Why?
|
Dietary Fiber | 4 | 2018 | 759 | 0.890 |
Why?
|
Colonic Pouches | 2 | 2022 | 122 | 0.890 |
Why?
|
Colon | 9 | 2023 | 1787 | 0.890 |
Why?
|
Sarcopenia | 2 | 2018 | 372 | 0.880 |
Why?
|
Colitis | 3 | 2021 | 1229 | 0.870 |
Why?
|
Recurrence | 16 | 2023 | 8426 | 0.870 |
Why?
|
Polyethylene Glycols | 4 | 2015 | 1189 | 0.860 |
Why?
|
Steroids | 2 | 2019 | 926 | 0.850 |
Why?
|
Antibodies, Monoclonal | 12 | 2019 | 9160 | 0.830 |
Why?
|
Odds Ratio | 19 | 2022 | 9650 | 0.820 |
Why?
|
Curcumin | 1 | 2023 | 98 | 0.820 |
Why?
|
Drug Monitoring | 5 | 2021 | 960 | 0.810 |
Why?
|
Quality of Life | 21 | 2024 | 13285 | 0.810 |
Why?
|
Follow-Up Studies | 40 | 2023 | 39059 | 0.800 |
Why?
|
Delivery, Obstetric | 3 | 2020 | 932 | 0.790 |
Why?
|
Alopecia Areata | 1 | 2024 | 127 | 0.790 |
Why?
|
Gastrointestinal Tract | 4 | 2021 | 829 | 0.780 |
Why?
|
Mucous Membrane | 2 | 2017 | 656 | 0.770 |
Why?
|
Pyoderma Gangrenosum | 2 | 2022 | 84 | 0.770 |
Why?
|
Inpatients | 7 | 2021 | 2551 | 0.770 |
Why?
|
Case-Control Studies | 31 | 2024 | 22029 | 0.760 |
Why?
|
Risk Assessment | 27 | 2021 | 23884 | 0.760 |
Why?
|
Wound Healing | 3 | 2019 | 2783 | 0.760 |
Why?
|
Logistic Models | 23 | 2024 | 13276 | 0.760 |
Why?
|
Breast Feeding | 4 | 2018 | 1355 | 0.750 |
Why?
|
Venous Thromboembolism | 4 | 2022 | 1855 | 0.750 |
Why?
|
Polypharmacy | 1 | 2024 | 305 | 0.750 |
Why?
|
Age Factors | 23 | 2024 | 18358 | 0.750 |
Why?
|
Endoscopy, Gastrointestinal | 4 | 2017 | 867 | 0.740 |
Why?
|
Gastrointestinal Transit | 3 | 2017 | 99 | 0.730 |
Why?
|
Neoplasms | 12 | 2024 | 22032 | 0.710 |
Why?
|
Diet Surveys | 3 | 2020 | 1161 | 0.700 |
Why?
|
Opportunistic Infections | 2 | 2020 | 375 | 0.700 |
Why?
|
Pregnancy Complications | 5 | 2021 | 2942 | 0.690 |
Why?
|
Treatment Outcome | 41 | 2024 | 64378 | 0.690 |
Why?
|
C-Reactive Protein | 8 | 2023 | 3812 | 0.690 |
Why?
|
Adolescent | 55 | 2024 | 87892 | 0.680 |
Why?
|
Hospital Mortality | 9 | 2015 | 5272 | 0.680 |
Why?
|
Disease Progression | 15 | 2023 | 13468 | 0.680 |
Why?
|
Length of Stay | 12 | 2017 | 6439 | 0.670 |
Why?
|
Metagenomics | 2 | 2020 | 457 | 0.670 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 7 | 2019 | 2269 | 0.670 |
Why?
|
Second-Look Surgery | 1 | 2019 | 27 | 0.660 |
Why?
|
Liver Transplantation | 5 | 2020 | 2325 | 0.650 |
Why?
|
Psoriasis | 2 | 2019 | 938 | 0.650 |
Why?
|
United States | 52 | 2023 | 72136 | 0.630 |
Why?
|
Eosinophilic Esophagitis | 1 | 2021 | 192 | 0.590 |
Why?
|
Diet | 11 | 2024 | 8005 | 0.590 |
Why?
|
Puerperal Disorders | 1 | 2020 | 299 | 0.590 |
Why?
|
Comorbidity | 16 | 2022 | 10495 | 0.590 |
Why?
|
Dietary Fats | 2 | 2017 | 1991 | 0.590 |
Why?
|
Metabolomics | 3 | 2023 | 1629 | 0.590 |
Why?
|
International Classification of Diseases | 6 | 2020 | 892 | 0.590 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2017 | 45 | 0.590 |
Why?
|
Adrenal Cortex Hormones | 7 | 2024 | 1870 | 0.580 |
Why?
|
Health Care Costs | 4 | 2023 | 3245 | 0.580 |
Why?
|
Anal Canal | 3 | 2019 | 372 | 0.570 |
Why?
|
Registries | 12 | 2019 | 8175 | 0.560 |
Why?
|
Hospitals, Special | 1 | 2017 | 91 | 0.560 |
Why?
|
Patient Care Management | 1 | 2020 | 302 | 0.560 |
Why?
|
Anti-Bacterial Agents | 11 | 2024 | 7403 | 0.560 |
Why?
|
After-Hours Care | 1 | 2017 | 102 | 0.550 |
Why?
|
Chronic Disease | 12 | 2022 | 9267 | 0.550 |
Why?
|
Ambulatory Care | 3 | 2015 | 2768 | 0.550 |
Why?
|
Absenteeism | 1 | 2018 | 249 | 0.540 |
Why?
|
Gastrointestinal Diseases | 2 | 2018 | 1185 | 0.540 |
Why?
|
Health Services Research | 3 | 2016 | 1812 | 0.540 |
Why?
|
Malnutrition | 3 | 2021 | 639 | 0.540 |
Why?
|
Hygiene | 1 | 2016 | 94 | 0.530 |
Why?
|
Drug Tolerance | 1 | 2018 | 367 | 0.530 |
Why?
|
Sanitation | 1 | 2016 | 85 | 0.530 |
Why?
|
Proportional Hazards Models | 18 | 2019 | 12440 | 0.520 |
Why?
|
Aged, 80 and over | 29 | 2021 | 58683 | 0.520 |
Why?
|
Colonic Neoplasms | 3 | 2021 | 2523 | 0.510 |
Why?
|
Prognosis | 25 | 2020 | 29557 | 0.500 |
Why?
|
Time Factors | 25 | 2021 | 39872 | 0.490 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 782 | 0.490 |
Why?
|
Genotype | 14 | 2024 | 12945 | 0.490 |
Why?
|
Tobacco Smoke Pollution | 2 | 2018 | 812 | 0.490 |
Why?
|
Genetic Research | 2 | 2015 | 172 | 0.490 |
Why?
|
Methotrexate | 2 | 2019 | 1719 | 0.490 |
Why?
|
Hepatitis B, Chronic | 2 | 2016 | 403 | 0.490 |
Why?
|
Ostomy | 1 | 2014 | 29 | 0.490 |
Why?
|
Decision Support Techniques | 4 | 2014 | 1996 | 0.480 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 557 | 0.470 |
Why?
|
Immunocompromised Host | 1 | 2020 | 856 | 0.470 |
Why?
|
Arylamine N-Acetyltransferase | 1 | 2014 | 86 | 0.470 |
Why?
|
Immune System Diseases | 1 | 2017 | 258 | 0.470 |
Why?
|
Fatty Acids | 2 | 2023 | 1803 | 0.470 |
Why?
|
Natural Language Processing | 7 | 2019 | 1134 | 0.460 |
Why?
|
Bacteriological Techniques | 1 | 2015 | 279 | 0.450 |
Why?
|
Nod2 Signaling Adaptor Protein | 1 | 2014 | 86 | 0.450 |
Why?
|
Hepatitis C | 3 | 2015 | 1579 | 0.450 |
Why?
|
Polymorphism, Single Nucleotide | 16 | 2023 | 15773 | 0.450 |
Why?
|
Cyclosporine | 1 | 2016 | 777 | 0.440 |
Why?
|
Ileostomy | 1 | 2014 | 120 | 0.440 |
Why?
|
Azathioprine | 3 | 2013 | 356 | 0.440 |
Why?
|
Genetic Predisposition to Disease | 17 | 2024 | 17768 | 0.440 |
Why?
|
Algorithms | 15 | 2024 | 13961 | 0.440 |
Why?
|
Celiac Disease | 3 | 2021 | 822 | 0.440 |
Why?
|
Checklist | 1 | 2020 | 827 | 0.430 |
Why?
|
Perineum | 1 | 2014 | 208 | 0.430 |
Why?
|
Computer Security | 1 | 2015 | 260 | 0.430 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2015 | 156 | 0.420 |
Why?
|
Workload | 2 | 2009 | 847 | 0.420 |
Why?
|
Blood Sedimentation | 1 | 2014 | 234 | 0.420 |
Why?
|
Weight Gain | 2 | 2020 | 2346 | 0.420 |
Why?
|
Infection Control | 1 | 2020 | 982 | 0.420 |
Why?
|
Proteomics | 3 | 2021 | 3816 | 0.420 |
Why?
|
Intestinal Mucosa | 3 | 2023 | 3020 | 0.420 |
Why?
|
Chemoprevention | 2 | 2014 | 326 | 0.410 |
Why?
|
Medical Informatics | 3 | 2015 | 732 | 0.410 |
Why?
|
Endoscopy | 4 | 2022 | 1834 | 0.410 |
Why?
|
Salvage Therapy | 1 | 2019 | 1268 | 0.400 |
Why?
|
Physicians | 3 | 2020 | 4580 | 0.400 |
Why?
|
Physician's Role | 1 | 2019 | 917 | 0.400 |
Why?
|
Emergency Service, Hospital | 5 | 2020 | 7810 | 0.390 |
Why?
|
Cecal Neoplasms | 1 | 2011 | 26 | 0.390 |
Why?
|
Colonic Polyps | 2 | 2019 | 551 | 0.390 |
Why?
|
Meat | 1 | 2014 | 584 | 0.380 |
Why?
|
Cost-Benefit Analysis | 5 | 2016 | 5484 | 0.380 |
Why?
|
Drug Therapy | 1 | 2014 | 503 | 0.380 |
Why?
|
Abdominal Abscess | 1 | 2013 | 152 | 0.380 |
Why?
|
Zinc | 1 | 2015 | 687 | 0.380 |
Why?
|
Anxiety Disorders | 2 | 2013 | 2714 | 0.380 |
Why?
|
Drug Therapy, Combination | 8 | 2019 | 6293 | 0.380 |
Why?
|
Cross Infection | 3 | 2017 | 1432 | 0.380 |
Why?
|
Sleep | 3 | 2016 | 4744 | 0.370 |
Why?
|
Enteral Nutrition | 6 | 2023 | 785 | 0.370 |
Why?
|
Hospitals | 7 | 2022 | 3887 | 0.370 |
Why?
|
Confidentiality | 1 | 2015 | 610 | 0.370 |
Why?
|
Life Style | 4 | 2022 | 3886 | 0.360 |
Why?
|
Parturition | 1 | 2014 | 446 | 0.360 |
Why?
|
Health Status Indicators | 1 | 2016 | 970 | 0.360 |
Why?
|
Pedigree | 1 | 2018 | 4578 | 0.350 |
Why?
|
Ecology | 1 | 2010 | 103 | 0.350 |
Why?
|
DNA Methylation | 1 | 2024 | 4373 | 0.340 |
Why?
|
Depressive Disorder | 2 | 2013 | 3727 | 0.340 |
Why?
|
Population Surveillance | 3 | 2015 | 2606 | 0.340 |
Why?
|
North America | 3 | 2020 | 1276 | 0.340 |
Why?
|
Prevalence | 16 | 2024 | 15651 | 0.340 |
Why?
|
Esophageal and Gastric Varices | 2 | 2009 | 208 | 0.340 |
Why?
|
Depression | 5 | 2022 | 8057 | 0.330 |
Why?
|
Hepatitis B | 1 | 2015 | 701 | 0.330 |
Why?
|
Risk | 9 | 2024 | 9599 | 0.330 |
Why?
|
Boston | 6 | 2018 | 9304 | 0.320 |
Why?
|
Cesarean Section | 2 | 2014 | 1385 | 0.320 |
Why?
|
Anticoagulants | 3 | 2015 | 4777 | 0.320 |
Why?
|
Affect | 1 | 2016 | 1480 | 0.320 |
Why?
|
Glucocorticoids | 1 | 2018 | 2144 | 0.320 |
Why?
|
Diabetes Mellitus | 4 | 2015 | 5816 | 0.310 |
Why?
|
Feeding Behavior | 2 | 2020 | 3184 | 0.310 |
Why?
|
Intra-Abdominal Fat | 3 | 2018 | 608 | 0.310 |
Why?
|
Ruminococcus | 2 | 2018 | 11 | 0.310 |
Why?
|
Early Detection of Cancer | 4 | 2019 | 3211 | 0.310 |
Why?
|
Withholding Treatment | 1 | 2013 | 610 | 0.310 |
Why?
|
Contraceptives, Oral | 3 | 2018 | 554 | 0.310 |
Why?
|
Genetic Association Studies | 3 | 2016 | 2717 | 0.300 |
Why?
|
Arthritis, Rheumatoid | 4 | 2019 | 3755 | 0.300 |
Why?
|
Metagenome | 3 | 2024 | 450 | 0.300 |
Why?
|
Cross-Sectional Studies | 17 | 2024 | 25956 | 0.300 |
Why?
|
Wrist Injuries | 1 | 2010 | 214 | 0.300 |
Why?
|
Biological Factors | 2 | 2021 | 157 | 0.300 |
Why?
|
Hyperplasia | 2 | 2021 | 1154 | 0.300 |
Why?
|
Thrombosis | 1 | 2022 | 2929 | 0.300 |
Why?
|
Predictive Value of Tests | 9 | 2020 | 15225 | 0.290 |
Why?
|
Caroli Disease | 1 | 2007 | 12 | 0.290 |
Why?
|
Thromboembolism | 1 | 2014 | 996 | 0.290 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2009 | 389 | 0.290 |
Why?
|
Esophagoscopy | 1 | 2009 | 390 | 0.290 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2010 | 269 | 0.290 |
Why?
|
Digestive System Surgical Procedures | 3 | 2018 | 575 | 0.280 |
Why?
|
Treatment Failure | 4 | 2019 | 2640 | 0.280 |
Why?
|
Randomized Controlled Trials as Topic | 8 | 2021 | 10146 | 0.280 |
Why?
|
Data Interpretation, Statistical | 2 | 2019 | 2690 | 0.280 |
Why?
|
Diagnostic Techniques, Digestive System | 1 | 2007 | 46 | 0.280 |
Why?
|
Liver Failure, Acute | 1 | 2008 | 181 | 0.270 |
Why?
|
Confidence Intervals | 4 | 2014 | 2925 | 0.270 |
Why?
|
Postoperative Complications | 6 | 2024 | 15637 | 0.270 |
Why?
|
Aspirin | 3 | 2013 | 3131 | 0.260 |
Why?
|
Risk Adjustment | 1 | 2010 | 600 | 0.260 |
Why?
|
Office Visits | 1 | 2010 | 596 | 0.260 |
Why?
|
Ileum | 3 | 2023 | 555 | 0.260 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2018 | 2496 | 0.260 |
Why?
|
Regression Analysis | 6 | 2021 | 6354 | 0.260 |
Why?
|
Cost of Illness | 5 | 2023 | 1936 | 0.260 |
Why?
|
Drug Prescriptions | 1 | 2015 | 1668 | 0.250 |
Why?
|
Kaplan-Meier Estimate | 6 | 2024 | 6493 | 0.250 |
Why?
|
Quantitative Trait Loci | 2 | 2023 | 2100 | 0.250 |
Why?
|
Sex Factors | 8 | 2024 | 10504 | 0.250 |
Why?
|
Clinical Trials as Topic | 2 | 2022 | 7985 | 0.250 |
Why?
|
Age of Onset | 6 | 2018 | 3298 | 0.250 |
Why?
|
Biopsy | 4 | 2021 | 6768 | 0.240 |
Why?
|
Pyridines | 1 | 2016 | 2859 | 0.240 |
Why?
|
Polymorphism, Genetic | 2 | 2019 | 4284 | 0.240 |
Why?
|
Adenoma | 2 | 2013 | 2148 | 0.230 |
Why?
|
Referral and Consultation | 1 | 2017 | 3586 | 0.230 |
Why?
|
Intestines | 3 | 2019 | 1906 | 0.230 |
Why?
|
Disability Evaluation | 2 | 2010 | 1825 | 0.230 |
Why?
|
Research Design | 3 | 2018 | 6157 | 0.230 |
Why?
|
Databases, Factual | 8 | 2021 | 7980 | 0.230 |
Why?
|
Piperidines | 3 | 2023 | 1639 | 0.230 |
Why?
|
Spinal Fractures | 1 | 2010 | 702 | 0.220 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2016 | 2292 | 0.220 |
Why?
|
Child | 19 | 2024 | 79818 | 0.220 |
Why?
|
Health Services Accessibility | 3 | 2018 | 5404 | 0.220 |
Why?
|
Physicians, Primary Care | 1 | 2010 | 624 | 0.220 |
Why?
|
Cotinine | 1 | 2024 | 203 | 0.220 |
Why?
|
Hospitals, Teaching | 1 | 2008 | 1159 | 0.220 |
Why?
|
Liver Neoplasms | 2 | 2016 | 4313 | 0.220 |
Why?
|
Complement Factor B | 1 | 2023 | 72 | 0.220 |
Why?
|
Pregnancy | 10 | 2021 | 29742 | 0.220 |
Why?
|
Pandemics | 2 | 2020 | 8611 | 0.220 |
Why?
|
Cholinergic Antagonists | 1 | 2024 | 164 | 0.210 |
Why?
|
Wisconsin | 4 | 2012 | 122 | 0.210 |
Why?
|
Pyrimidines | 4 | 2023 | 3006 | 0.210 |
Why?
|
Esters | 1 | 2023 | 209 | 0.210 |
Why?
|
Patient Care | 1 | 2008 | 622 | 0.210 |
Why?
|
Models, Statistical | 5 | 2020 | 5070 | 0.210 |
Why?
|
Nutritional Status | 2 | 2021 | 1607 | 0.210 |
Why?
|
Telemedicine | 1 | 2020 | 3018 | 0.210 |
Why?
|
DNA | 1 | 2016 | 7199 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3076 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3196 | 0.200 |
Why?
|
Erythema Nodosum | 1 | 2022 | 31 | 0.200 |
Why?
|
Patient Acceptance of Health Care | 2 | 2015 | 3175 | 0.200 |
Why?
|
Hip Fractures | 1 | 2010 | 987 | 0.200 |
Why?
|
Proctitis | 1 | 2022 | 41 | 0.200 |
Why?
|
Tooth Loss | 1 | 2023 | 198 | 0.190 |
Why?
|
Combined Modality Therapy | 3 | 2019 | 8530 | 0.190 |
Why?
|
Bile Acids and Salts | 1 | 2023 | 383 | 0.190 |
Why?
|
Constriction, Pathologic | 3 | 2023 | 1097 | 0.190 |
Why?
|
Inappropriate Prescribing | 1 | 2024 | 209 | 0.190 |
Why?
|
Amides | 1 | 2023 | 447 | 0.190 |
Why?
|
Acute Disease | 3 | 2024 | 7225 | 0.180 |
Why?
|
Quality-Adjusted Life Years | 3 | 2013 | 1722 | 0.180 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 3227 | 0.180 |
Why?
|
Area Under Curve | 3 | 2018 | 1632 | 0.180 |
Why?
|
Infant | 7 | 2024 | 36055 | 0.180 |
Why?
|
Liver Cirrhosis | 4 | 2015 | 1930 | 0.180 |
Why?
|
Alberta | 1 | 2020 | 66 | 0.180 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 3526 | 0.180 |
Why?
|
Pneumonia | 1 | 2012 | 2129 | 0.180 |
Why?
|
Self Report | 3 | 2020 | 3714 | 0.180 |
Why?
|
Mesalamine | 4 | 2023 | 136 | 0.180 |
Why?
|
Dietary Supplements | 4 | 2018 | 3387 | 0.170 |
Why?
|
Glutens | 2 | 2021 | 240 | 0.170 |
Why?
|
Periodontal Diseases | 1 | 2023 | 451 | 0.170 |
Why?
|
Vancomycin | 2 | 2015 | 503 | 0.170 |
Why?
|
Alleles | 5 | 2019 | 6895 | 0.170 |
Why?
|
Inflammation | 8 | 2023 | 10718 | 0.170 |
Why?
|
Hemoglobins | 2 | 2018 | 1519 | 0.170 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2022 | 278 | 0.170 |
Why?
|
Histological Techniques | 1 | 2019 | 194 | 0.170 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 2022 | 240 | 0.170 |
Why?
|
Tomography, X-Ray Computed | 3 | 2019 | 20500 | 0.170 |
Why?
|
Socioeconomic Factors | 4 | 2017 | 7818 | 0.160 |
Why?
|
Periodontitis | 1 | 2024 | 558 | 0.160 |
Why?
|
Child, Preschool | 8 | 2020 | 42062 | 0.160 |
Why?
|
Estrogen Replacement Therapy | 2 | 2018 | 1206 | 0.160 |
Why?
|
Infant, Newborn | 6 | 2020 | 26183 | 0.160 |
Why?
|
Penetrance | 1 | 2021 | 388 | 0.160 |
Why?
|
Longitudinal Studies | 5 | 2023 | 14490 | 0.160 |
Why?
|
Budesonide | 3 | 2023 | 158 | 0.160 |
Why?
|
ROC Curve | 2 | 2018 | 3563 | 0.160 |
Why?
|
Blood | 1 | 2021 | 586 | 0.160 |
Why?
|
Veillonella | 1 | 2018 | 21 | 0.160 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2019 | 9273 | 0.160 |
Why?
|
Asia | 2 | 2017 | 616 | 0.160 |
Why?
|
Prebiotics | 1 | 2018 | 41 | 0.160 |
Why?
|
Chi-Square Distribution | 3 | 2018 | 3425 | 0.160 |
Why?
|
Sigmoidoscopy | 1 | 2019 | 151 | 0.160 |
Why?
|
Adenomatous Polyps | 1 | 2019 | 108 | 0.160 |
Why?
|
Pyrophosphatases | 1 | 2019 | 139 | 0.160 |
Why?
|
Paper | 1 | 2018 | 84 | 0.160 |
Why?
|
Barrett Esophagus | 2 | 2013 | 490 | 0.160 |
Why?
|
Manometry | 3 | 2015 | 453 | 0.150 |
Why?
|
Vaginal Diseases | 1 | 2019 | 103 | 0.150 |
Why?
|
Colitis, Lymphocytic | 1 | 2018 | 23 | 0.150 |
Why?
|
Colitis, Collagenous | 1 | 2018 | 25 | 0.150 |
Why?
|
Body Mass Index | 9 | 2023 | 12876 | 0.150 |
Why?
|
Uveitis | 1 | 2022 | 393 | 0.150 |
Why?
|
Research Subjects | 1 | 2020 | 249 | 0.150 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2024 | 1136 | 0.150 |
Why?
|
Sepsis | 1 | 2012 | 2587 | 0.150 |
Why?
|
Survival Rate | 4 | 2014 | 12721 | 0.150 |
Why?
|
Liver Function Tests | 3 | 2015 | 523 | 0.150 |
Why?
|
Delivery of Health Care | 2 | 2020 | 5331 | 0.150 |
Why?
|
Massachusetts | 6 | 2018 | 8823 | 0.150 |
Why?
|
Adiposity | 2 | 2018 | 1858 | 0.150 |
Why?
|
Sex Hormone-Binding Globulin | 2 | 2022 | 546 | 0.150 |
Why?
|
Autoimmune Diseases | 2 | 2024 | 2244 | 0.140 |
Why?
|
HIV Infections | 3 | 2016 | 17275 | 0.140 |
Why?
|
Laparoscopy | 1 | 2009 | 2147 | 0.140 |
Why?
|
Nicotine | 1 | 2022 | 677 | 0.140 |
Why?
|
Lung Diseases | 1 | 2007 | 1910 | 0.140 |
Why?
|
Stress, Psychological | 3 | 2018 | 4455 | 0.140 |
Why?
|
Tuberculosis, Gastrointestinal | 1 | 2016 | 21 | 0.140 |
Why?
|
Medicare | 3 | 2021 | 6741 | 0.140 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2018 | 189 | 0.140 |
Why?
|
Mortality | 2 | 2019 | 2886 | 0.140 |
Why?
|
Linear Models | 3 | 2018 | 5862 | 0.140 |
Why?
|
Genome-Wide Association Study | 7 | 2023 | 12604 | 0.140 |
Why?
|
Patients | 1 | 2023 | 904 | 0.140 |
Why?
|
Air Pollution | 1 | 2010 | 2314 | 0.140 |
Why?
|
Survival Analysis | 3 | 2016 | 10112 | 0.140 |
Why?
|
Abortion, Spontaneous | 1 | 2021 | 530 | 0.140 |
Why?
|
Arthritis | 1 | 2022 | 666 | 0.140 |
Why?
|
Iron, Dietary | 1 | 2017 | 148 | 0.140 |
Why?
|
Butyrates | 1 | 2017 | 168 | 0.130 |
Why?
|
Pets | 1 | 2016 | 47 | 0.130 |
Why?
|
Fluorocarbons | 1 | 2021 | 489 | 0.130 |
Why?
|
Drug Substitution | 1 | 2019 | 288 | 0.130 |
Why?
|
Synthetic Biology | 1 | 2018 | 185 | 0.130 |
Why?
|
Health Surveys | 6 | 2018 | 4064 | 0.130 |
Why?
|
Methyltransferases | 1 | 2019 | 374 | 0.130 |
Why?
|
Reproductive History | 2 | 2018 | 211 | 0.130 |
Why?
|
Consensus | 2 | 2022 | 3099 | 0.130 |
Why?
|
Patient Readmission | 3 | 2021 | 3261 | 0.130 |
Why?
|
Heme | 1 | 2017 | 313 | 0.120 |
Why?
|
Vitamin D-Binding Protein | 1 | 2016 | 131 | 0.120 |
Why?
|
Lymphoma | 1 | 2024 | 1896 | 0.120 |
Why?
|
Netherlands | 1 | 2020 | 2212 | 0.120 |
Why?
|
Multifactorial Inheritance | 1 | 2023 | 1365 | 0.120 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2018 | 357 | 0.120 |
Why?
|
Mass Screening | 2 | 2011 | 5427 | 0.120 |
Why?
|
Hospital Costs | 2 | 2013 | 960 | 0.120 |
Why?
|
Androgens | 1 | 2022 | 1291 | 0.120 |
Why?
|
Dermatologic Agents | 1 | 2019 | 308 | 0.120 |
Why?
|
Colon, Sigmoid | 1 | 2015 | 124 | 0.120 |
Why?
|
Disease | 1 | 2020 | 671 | 0.120 |
Why?
|
NAD(P)H Dehydrogenase (Quinone) | 1 | 2014 | 56 | 0.120 |
Why?
|
Arthralgia | 1 | 2018 | 461 | 0.120 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7378 | 0.120 |
Why?
|
Glutathione S-Transferase pi | 1 | 2014 | 100 | 0.110 |
Why?
|
Rectal Fistula | 1 | 2014 | 75 | 0.110 |
Why?
|
GTP-Binding Proteins | 1 | 2018 | 950 | 0.110 |
Why?
|
Pelvic Floor | 1 | 2015 | 138 | 0.110 |
Why?
|
Nervous System Diseases | 1 | 2024 | 1647 | 0.110 |
Why?
|
International Normalized Ratio | 1 | 2015 | 382 | 0.110 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 933 | 0.110 |
Why?
|
Propensity Score | 3 | 2020 | 1907 | 0.110 |
Why?
|
Nurses | 2 | 2021 | 2467 | 0.110 |
Why?
|
Cation Transport Proteins | 1 | 2016 | 324 | 0.110 |
Why?
|
Th1 Cells | 1 | 2019 | 1031 | 0.110 |
Why?
|
Postpartum Period | 1 | 2020 | 1167 | 0.110 |
Why?
|
Patient Care Planning | 1 | 2019 | 907 | 0.110 |
Why?
|
Primary Health Care | 1 | 2010 | 4652 | 0.110 |
Why?
|
Models, Genetic | 2 | 2014 | 3441 | 0.110 |
Why?
|
Immune Tolerance | 1 | 2023 | 2297 | 0.110 |
Why?
|
Smad3 Protein | 1 | 2014 | 166 | 0.110 |
Why?
|
Hepatic Encephalopathy | 3 | 2011 | 144 | 0.110 |
Why?
|
Abdominal Pain | 1 | 2020 | 1063 | 0.110 |
Why?
|
SEER Program | 1 | 2019 | 1530 | 0.110 |
Why?
|
Health Resources | 1 | 2019 | 931 | 0.110 |
Why?
|
Repressor Proteins | 1 | 2024 | 2980 | 0.110 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2379 | 0.110 |
Why?
|
Immunity, Humoral | 1 | 2017 | 604 | 0.110 |
Why?
|
Antibodies | 1 | 2021 | 2420 | 0.110 |
Why?
|
Metabolome | 1 | 2020 | 982 | 0.110 |
Why?
|
Metronidazole | 2 | 2013 | 231 | 0.110 |
Why?
|
Europe | 1 | 2020 | 3420 | 0.110 |
Why?
|
Drug Resistance | 1 | 2019 | 1593 | 0.110 |
Why?
|
Biofeedback, Psychology | 1 | 2013 | 116 | 0.100 |
Why?
|
Integrins | 1 | 2017 | 836 | 0.100 |
Why?
|
Gastric Juice | 1 | 2012 | 59 | 0.100 |
Why?
|
Health Status | 2 | 2020 | 4071 | 0.100 |
Why?
|
Alcohol Drinking | 2 | 2022 | 4018 | 0.100 |
Why?
|
Seafood | 1 | 2015 | 390 | 0.100 |
Why?
|
Pyrroles | 1 | 2019 | 1130 | 0.100 |
Why?
|
Th17 Cells | 1 | 2019 | 785 | 0.100 |
Why?
|
Reference Values | 1 | 2019 | 4919 | 0.100 |
Why?
|
Alanine Transaminase | 1 | 2015 | 604 | 0.100 |
Why?
|
Siblings | 1 | 2016 | 824 | 0.100 |
Why?
|
Gastric Acid | 1 | 2012 | 98 | 0.100 |
Why?
|
Defecation | 1 | 2013 | 190 | 0.100 |
Why?
|
Glutathione Transferase | 1 | 2014 | 564 | 0.100 |
Why?
|
Data Mining | 1 | 2017 | 551 | 0.100 |
Why?
|
Genetic Markers | 1 | 2018 | 2608 | 0.100 |
Why?
|
Quality Control | 1 | 2014 | 825 | 0.100 |
Why?
|
Obesity | 4 | 2018 | 12870 | 0.100 |
Why?
|
Vomiting | 2 | 2012 | 651 | 0.100 |
Why?
|
Government Programs | 1 | 2014 | 279 | 0.100 |
Why?
|
Heme Oxygenase-1 | 1 | 2014 | 363 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2023 | 1887 | 0.100 |
Why?
|
Catheters, Indwelling | 1 | 2014 | 428 | 0.100 |
Why?
|
Integrin alpha4 | 1 | 2011 | 87 | 0.100 |
Why?
|
Thrombophilia | 1 | 2014 | 304 | 0.090 |
Why?
|
Triazoles | 1 | 2016 | 902 | 0.090 |
Why?
|
Hospital Charges | 2 | 2010 | 357 | 0.090 |
Why?
|
Mycobacterium | 1 | 2012 | 250 | 0.090 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2014 | 506 | 0.090 |
Why?
|
Parenteral Nutrition, Total | 1 | 2012 | 303 | 0.090 |
Why?
|
Histamine H2 Antagonists | 1 | 2012 | 165 | 0.090 |
Why?
|
Appendectomy | 1 | 2014 | 431 | 0.090 |
Why?
|
Carnitine | 1 | 2012 | 252 | 0.090 |
Why?
|
Stress, Physiological | 1 | 2018 | 1398 | 0.090 |
Why?
|
Ubiquinone | 1 | 2012 | 182 | 0.090 |
Why?
|
Autonomic Pathways | 1 | 2010 | 31 | 0.090 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 3754 | 0.090 |
Why?
|
Community-Acquired Infections | 1 | 2014 | 460 | 0.090 |
Why?
|
Meta-Analysis as Topic | 1 | 2015 | 1373 | 0.090 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2015 | 706 | 0.090 |
Why?
|
Herb-Drug Interactions | 1 | 2010 | 9 | 0.090 |
Why?
|
Laparotomy | 1 | 2013 | 465 | 0.090 |
Why?
|
Gene Expression Profiling | 2 | 2024 | 9404 | 0.090 |
Why?
|
Stem Cell Transplantation | 1 | 2019 | 1599 | 0.090 |
Why?
|
Panax | 1 | 2010 | 28 | 0.090 |
Why?
|
Rectum | 1 | 2015 | 895 | 0.090 |
Why?
|
Patient Discharge | 4 | 2022 | 3433 | 0.090 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2012 | 431 | 0.090 |
Why?
|
Reproducibility of Results | 5 | 2023 | 20055 | 0.090 |
Why?
|
Tuberculin Test | 1 | 2011 | 206 | 0.090 |
Why?
|
Lipoproteins, LDL | 1 | 2013 | 640 | 0.090 |
Why?
|
Disease Management | 2 | 2019 | 2500 | 0.090 |
Why?
|
Fruit | 1 | 2015 | 1160 | 0.090 |
Why?
|
Species Specificity | 3 | 2019 | 2417 | 0.090 |
Why?
|
Vegetables | 1 | 2015 | 1195 | 0.090 |
Why?
|
Graft vs Host Disease | 1 | 2022 | 3024 | 0.090 |
Why?
|
Oxidative Stress | 2 | 2018 | 3099 | 0.090 |
Why?
|
Patient Selection | 3 | 2021 | 4244 | 0.090 |
Why?
|
New England | 1 | 2013 | 1053 | 0.090 |
Why?
|
Proton Pump Inhibitors | 2 | 2012 | 529 | 0.090 |
Why?
|
Colitis, Ischemic | 1 | 2009 | 32 | 0.080 |
Why?
|
Decision Trees | 1 | 2011 | 504 | 0.080 |
Why?
|
Testosterone | 2 | 2022 | 2471 | 0.080 |
Why?
|
Sick Leave | 1 | 2010 | 105 | 0.080 |
Why?
|
Hemostasis, Endoscopic | 1 | 2009 | 40 | 0.080 |
Why?
|
Phylogeny | 3 | 2024 | 2774 | 0.080 |
Why?
|
Pennsylvania | 1 | 2010 | 614 | 0.080 |
Why?
|
Portasystemic Shunt, Surgical | 1 | 2008 | 39 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2019 | 2215 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2019 | 10748 | 0.080 |
Why?
|
Psychometrics | 1 | 2018 | 3052 | 0.080 |
Why?
|
Injections, Subcutaneous | 1 | 2010 | 677 | 0.080 |
Why?
|
Vaccines | 1 | 2017 | 832 | 0.080 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2016 | 1348 | 0.080 |
Why?
|
Serum Albumin | 1 | 2012 | 673 | 0.080 |
Why?
|
Data Collection | 2 | 2010 | 3322 | 0.080 |
Why?
|
Healthcare Disparities | 2 | 2018 | 3364 | 0.080 |
Why?
|
Diverticulum | 1 | 2009 | 137 | 0.080 |
Why?
|
Hormone Replacement Therapy | 1 | 2014 | 754 | 0.080 |
Why?
|
Medically Underserved Area | 1 | 2010 | 257 | 0.080 |
Why?
|
Quality Indicators, Health Care | 2 | 2019 | 1797 | 0.080 |
Why?
|
Antitubercular Agents | 1 | 2016 | 1373 | 0.080 |
Why?
|
Genetic Testing | 2 | 2018 | 3530 | 0.080 |
Why?
|
Risk Reduction Behavior | 1 | 2014 | 1098 | 0.070 |
Why?
|
Latent Tuberculosis | 1 | 2011 | 224 | 0.070 |
Why?
|
Cytomegalovirus Infections | 1 | 2014 | 831 | 0.070 |
Why?
|
Exercise | 1 | 2024 | 5788 | 0.070 |
Why?
|
Attitude of Health Personnel | 2 | 2016 | 3867 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2872 | 0.070 |
Why?
|
Fellowships and Scholarships | 1 | 2016 | 1115 | 0.070 |
Why?
|
Cholagogues and Choleretics | 1 | 2007 | 37 | 0.070 |
Why?
|
Eye Diseases | 2 | 2024 | 651 | 0.070 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2023 | 1006 | 0.070 |
Why?
|
Warfarin | 1 | 2015 | 1482 | 0.070 |
Why?
|
Ursodeoxycholic Acid | 1 | 2007 | 79 | 0.070 |
Why?
|
Drainage | 1 | 2013 | 1161 | 0.070 |
Why?
|
Mutation, Missense | 1 | 2016 | 2564 | 0.070 |
Why?
|
Tuberculosis | 1 | 2020 | 2001 | 0.070 |
Why?
|
Liver Diseases | 1 | 2015 | 1296 | 0.070 |
Why?
|
Illinois | 1 | 2007 | 118 | 0.070 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2007 | 100 | 0.070 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 3242 | 0.070 |
Why?
|
Schools | 1 | 2015 | 1482 | 0.070 |
Why?
|
Eating | 1 | 2013 | 1536 | 0.070 |
Why?
|
Cytokines | 1 | 2021 | 7338 | 0.070 |
Why?
|
Creatinine | 1 | 2012 | 1892 | 0.070 |
Why?
|
Anxiety | 2 | 2022 | 4539 | 0.070 |
Why?
|
Pancreatic Neoplasms | 1 | 2024 | 5349 | 0.070 |
Why?
|
Cholangitis | 1 | 2007 | 113 | 0.070 |
Why?
|
Escherichia coli | 1 | 2018 | 4215 | 0.070 |
Why?
|
Placebos | 1 | 2010 | 1661 | 0.060 |
Why?
|
Interleukin-6 | 1 | 2016 | 3208 | 0.060 |
Why?
|
Dyslipidemias | 1 | 2013 | 867 | 0.060 |
Why?
|
Animals | 8 | 2023 | 167768 | 0.060 |
Why?
|
Florida | 1 | 2007 | 431 | 0.060 |
Why?
|
Gene Expression Regulation | 1 | 2023 | 11892 | 0.060 |
Why?
|
Emergency Treatment | 1 | 2009 | 496 | 0.060 |
Why?
|
Patient Admission | 1 | 2013 | 1372 | 0.060 |
Why?
|
Radiopharmaceuticals | 1 | 2015 | 2634 | 0.060 |
Why?
|
Multicenter Studies as Topic | 1 | 2010 | 1705 | 0.060 |
Why?
|
Secondary Prevention | 1 | 2011 | 1474 | 0.060 |
Why?
|
Multiple Sclerosis | 2 | 2024 | 3204 | 0.060 |
Why?
|
Hypertension, Portal | 1 | 2007 | 226 | 0.060 |
Why?
|
Demography | 1 | 2009 | 1651 | 0.060 |
Why?
|
Balloon Occlusion | 1 | 2005 | 125 | 0.060 |
Why?
|
New York | 1 | 2007 | 874 | 0.060 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2006 | 320 | 0.060 |
Why?
|
Education, Medical | 1 | 2016 | 1725 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2022 | 5649 | 0.060 |
Why?
|
Skin Diseases | 2 | 2024 | 1088 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3765 | 0.060 |
Why?
|
Fatty Liver | 1 | 2010 | 777 | 0.060 |
Why?
|
Host-Pathogen Interactions | 1 | 2012 | 1444 | 0.060 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2016 | 2125 | 0.060 |
Why?
|
Sample Size | 2 | 2019 | 838 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2016 | 2359 | 0.060 |
Why?
|
Transcription, Genetic | 1 | 2018 | 7590 | 0.060 |
Why?
|
Probability | 1 | 2009 | 2467 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2015 | 2747 | 0.060 |
Why?
|
Motor Activity | 1 | 2013 | 2685 | 0.060 |
Why?
|
Clostridium | 1 | 2023 | 100 | 0.060 |
Why?
|
Reoperation | 1 | 2014 | 4282 | 0.050 |
Why?
|
Bifidobacterium | 1 | 2023 | 98 | 0.050 |
Why?
|
Mycobacterium tuberculosis | 2 | 2012 | 1903 | 0.050 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 12951 | 0.050 |
Why?
|
Sulfasalazine | 1 | 2023 | 84 | 0.050 |
Why?
|
Spondylitis, Ankylosing | 1 | 2024 | 152 | 0.050 |
Why?
|
Educational Status | 1 | 2010 | 2513 | 0.050 |
Why?
|
Curriculum | 1 | 2016 | 3717 | 0.050 |
Why?
|
Accidents, Traffic | 1 | 2008 | 814 | 0.050 |
Why?
|
Bacteria | 2 | 2024 | 2197 | 0.050 |
Why?
|
Phenols | 1 | 2006 | 514 | 0.050 |
Why?
|
Enterococcus | 1 | 2023 | 160 | 0.050 |
Why?
|
Food Handling | 1 | 2023 | 155 | 0.050 |
Why?
|
Lactoferrin | 1 | 2023 | 100 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2017 | 4317 | 0.050 |
Why?
|
Lactobacillus | 1 | 2023 | 204 | 0.050 |
Why?
|
Acetaminophen | 1 | 2006 | 552 | 0.050 |
Why?
|
Anticonvulsants | 1 | 2012 | 1881 | 0.050 |
Why?
|
Hormones | 2 | 2019 | 869 | 0.050 |
Why?
|
Health Care Surveys | 1 | 2009 | 2432 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6313 | 0.050 |
Why?
|
Income | 1 | 2010 | 1872 | 0.050 |
Why?
|
Substance Abuse, Intravenous | 1 | 2006 | 529 | 0.050 |
Why?
|
Venous Thrombosis | 1 | 2011 | 1292 | 0.050 |
Why?
|
Genomics | 1 | 2017 | 5790 | 0.050 |
Why?
|
Osteoporosis | 1 | 2010 | 1598 | 0.050 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11152 | 0.050 |
Why?
|
Menopause | 2 | 2019 | 1639 | 0.050 |
Why?
|
Computer Simulation | 3 | 2020 | 6201 | 0.050 |
Why?
|
Methylprednisolone | 1 | 2022 | 384 | 0.040 |
Why?
|
Genetic Variation | 1 | 2015 | 6548 | 0.040 |
Why?
|
Societies, Medical | 2 | 2019 | 3891 | 0.040 |
Why?
|
Medical Illustration | 1 | 2021 | 135 | 0.040 |
Why?
|
Coronary Artery Disease | 2 | 2020 | 6362 | 0.040 |
Why?
|
Catheterization | 1 | 2005 | 1426 | 0.040 |
Why?
|
Forecasting | 1 | 2009 | 2923 | 0.040 |
Why?
|
Haplotypes | 2 | 2019 | 2764 | 0.040 |
Why?
|
Computational Biology | 2 | 2024 | 3502 | 0.040 |
Why?
|
Analgesics | 1 | 2006 | 1064 | 0.040 |
Why?
|
Plasma Cells | 1 | 2023 | 591 | 0.040 |
Why?
|
Piperazines | 1 | 2010 | 2511 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2023 | 979 | 0.040 |
Why?
|
Necrosis | 1 | 2023 | 1604 | 0.040 |
Why?
|
Obesity, Morbid | 1 | 2010 | 1277 | 0.040 |
Why?
|
Women's Health | 2 | 2019 | 2057 | 0.040 |
Why?
|
Thrombospondins | 1 | 2019 | 193 | 0.040 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2024 | 708 | 0.040 |
Why?
|
Bacteroides | 1 | 2019 | 165 | 0.040 |
Why?
|
Clinical Competence | 2 | 2016 | 4775 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 14641 | 0.040 |
Why?
|
Vagina | 1 | 2023 | 838 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2012 | 13591 | 0.040 |
Why?
|
Liver | 2 | 2012 | 7502 | 0.040 |
Why?
|
Ciprofloxacin | 1 | 2020 | 312 | 0.040 |
Why?
|
Enterocytes | 1 | 2019 | 220 | 0.040 |
Why?
|
Patient Satisfaction | 1 | 2010 | 3446 | 0.040 |
Why?
|
Prescriptions | 1 | 2020 | 387 | 0.040 |
Why?
|
Tetanus Toxin | 1 | 2017 | 46 | 0.040 |
Why?
|
Automation | 1 | 2020 | 580 | 0.040 |
Why?
|
Gene Knock-In Techniques | 1 | 2019 | 419 | 0.040 |
Why?
|
Bone Density | 1 | 2010 | 3533 | 0.040 |
Why?
|
Pulmonary Embolism | 1 | 2011 | 2540 | 0.040 |
Why?
|
Tandem Mass Spectrometry | 1 | 2023 | 1186 | 0.040 |
Why?
|
Models, Biological | 1 | 2013 | 9460 | 0.040 |
Why?
|
Phagocytosis | 1 | 2023 | 1533 | 0.040 |
Why?
|
Antigens, Bacterial | 1 | 2023 | 1155 | 0.040 |
Why?
|
Haemophilus influenzae | 1 | 2017 | 180 | 0.040 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2024 | 1373 | 0.040 |
Why?
|
Hodgkin Disease | 1 | 2024 | 1377 | 0.030 |
Why?
|
Sequence Analysis, DNA | 2 | 2019 | 4711 | 0.030 |
Why?
|
Fungi | 1 | 2019 | 339 | 0.030 |
Why?
|
Melena | 1 | 2015 | 32 | 0.030 |
Why?
|
Health | 1 | 2019 | 398 | 0.030 |
Why?
|
Aftercare | 1 | 2022 | 910 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15399 | 0.030 |
Why?
|
Mice | 3 | 2019 | 81101 | 0.030 |
Why?
|
Wounds and Injuries | 1 | 2008 | 2476 | 0.030 |
Why?
|
Frail Elderly | 1 | 2021 | 751 | 0.030 |
Why?
|
Viruses | 1 | 2019 | 376 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 2019 | 983 | 0.030 |
Why?
|
Estradiol | 1 | 2022 | 1933 | 0.030 |
Why?
|
Genetic Pleiotropy | 1 | 2016 | 181 | 0.030 |
Why?
|
Administrative Personnel | 1 | 2016 | 182 | 0.030 |
Why?
|
Academic Medical Centers | 2 | 2015 | 2751 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2019 | 1593 | 0.030 |
Why?
|
Rheumatic Diseases | 1 | 2022 | 639 | 0.030 |
Why?
|
Capsule Endoscopy | 1 | 2015 | 100 | 0.030 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2016 | 301 | 0.030 |
Why?
|
Smoking Cessation | 2 | 2018 | 2055 | 0.030 |
Why?
|
Patient Preference | 1 | 2021 | 921 | 0.030 |
Why?
|
Spasm | 1 | 2014 | 130 | 0.030 |
Why?
|
Energy Intake | 1 | 2021 | 2127 | 0.030 |
Why?
|
Indiana | 1 | 2013 | 92 | 0.030 |
Why?
|
Sexual Behavior | 2 | 2018 | 2158 | 0.030 |
Why?
|
Endoscopy, Digestive System | 1 | 2016 | 351 | 0.030 |
Why?
|
Immune System | 1 | 2019 | 796 | 0.030 |
Why?
|
Interleukin-17 | 1 | 2019 | 908 | 0.030 |
Why?
|
Medical Audit | 1 | 2014 | 452 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2021 | 4839 | 0.030 |
Why?
|
Gastric Acidity Determination | 1 | 2012 | 56 | 0.030 |
Why?
|
Genome, Bacterial | 1 | 2017 | 770 | 0.030 |
Why?
|
Plasma | 1 | 2016 | 584 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2018 | 12759 | 0.030 |
Why?
|
Lipids | 1 | 2023 | 3326 | 0.020 |
Why?
|
Mycobacterium Infections | 1 | 2012 | 121 | 0.020 |
Why?
|
British Columbia | 1 | 2012 | 240 | 0.020 |
Why?
|
Pressure | 1 | 2015 | 1155 | 0.020 |
Why?
|
Hospitals, University | 1 | 2013 | 567 | 0.020 |
Why?
|
Mutation | 1 | 2016 | 29915 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2021 | 6068 | 0.020 |
Why?
|
Antibodies, Bacterial | 1 | 2017 | 1468 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2015 | 1975 | 0.020 |
Why?
|
India | 1 | 2018 | 2329 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2023 | 4353 | 0.020 |
Why?
|
Protein Transport | 1 | 2016 | 1963 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1651 | 0.020 |
Why?
|
Parkinson Disease | 1 | 2024 | 2862 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2015 | 772 | 0.020 |
Why?
|
Liver Failure | 1 | 2012 | 249 | 0.020 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2011 | 187 | 0.020 |
Why?
|
Diagnostic Tests, Routine | 1 | 2016 | 787 | 0.020 |
Why?
|
Dementia | 1 | 2024 | 2650 | 0.020 |
Why?
|
Genetic Loci | 1 | 2019 | 2612 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2013 | 1705 | 0.020 |
Why?
|
Sweating | 1 | 2010 | 154 | 0.020 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2010 | 114 | 0.020 |
Why?
|
Geography | 1 | 2012 | 660 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2006 | 4402 | 0.020 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 821 | 0.020 |
Why?
|
Proteins | 1 | 2024 | 6026 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 931 | 0.020 |
Why?
|
Epilepsy | 1 | 2024 | 3269 | 0.020 |
Why?
|
Ascites | 1 | 2011 | 338 | 0.020 |
Why?
|
Liver Cirrhosis, Alcoholic | 1 | 2008 | 64 | 0.020 |
Why?
|
Morbidity | 1 | 2014 | 1754 | 0.020 |
Why?
|
Health Services | 1 | 2013 | 752 | 0.020 |
Why?
|
Diarrhea | 1 | 2014 | 1317 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2012 | 2497 | 0.020 |
Why?
|
Benchmarking | 1 | 2013 | 1042 | 0.020 |
Why?
|
Hypertriglyceridemia | 1 | 2010 | 293 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 3991 | 0.020 |
Why?
|
Carrageenan | 1 | 2006 | 70 | 0.020 |
Why?
|
Observer Variation | 1 | 2013 | 2600 | 0.020 |
Why?
|
Posture | 1 | 2010 | 953 | 0.020 |
Why?
|
Anemia | 1 | 2015 | 1504 | 0.020 |
Why?
|
Parenteral Nutrition | 1 | 2011 | 656 | 0.020 |
Why?
|
Peptides | 1 | 2018 | 4341 | 0.020 |
Why?
|
Thailand | 1 | 2006 | 288 | 0.020 |
Why?
|
Autonomic Nervous System | 1 | 2010 | 697 | 0.020 |
Why?
|
Anti-Infective Agents | 1 | 2013 | 981 | 0.020 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 685 | 0.020 |
Why?
|
Birth Weight | 1 | 2013 | 2097 | 0.010 |
Why?
|
Contrast Media | 1 | 2017 | 5298 | 0.010 |
Why?
|
Benzamides | 1 | 2010 | 1368 | 0.010 |
Why?
|
Cyclooxygenase 2 | 1 | 2006 | 597 | 0.010 |
Why?
|
Infant, Premature | 1 | 2013 | 2092 | 0.010 |
Why?
|
Postmenopause | 1 | 2012 | 2509 | 0.010 |
Why?
|
Hepatitis C, Chronic | 1 | 2011 | 1031 | 0.010 |
Why?
|
Edema | 1 | 2006 | 768 | 0.010 |
Why?
|
Stroke | 1 | 2024 | 9694 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2012 | 2058 | 0.010 |
Why?
|
Patient Compliance | 1 | 2012 | 2685 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10171 | 0.010 |
Why?
|
Software | 1 | 2014 | 4415 | 0.010 |
Why?
|
Respiration, Artificial | 1 | 2011 | 2618 | 0.010 |
Why?
|
Genome, Human | 1 | 2012 | 4416 | 0.010 |
Why?
|
Heart Rate | 1 | 2010 | 4166 | 0.010 |
Why?
|
Fever | 1 | 2006 | 1617 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2006 | 2204 | 0.010 |
Why?
|
Pain Measurement | 1 | 2006 | 3527 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2006 | 8143 | 0.010 |
Why?
|
Blood Pressure | 1 | 2010 | 8451 | 0.010 |
Why?
|
Internet | 1 | 2005 | 3082 | 0.010 |
Why?
|
Rats | 1 | 2006 | 23679 | 0.010 |
Why?
|